By Associate Professor Suzanne Jean Hodgkinson

Conference Abstracts

Harding-Forrester S; Roos I; Nguyen AL; Malpas CB; Diouf I; Moradi N; Sharmin S; Izquierdo G; Eichau S; Patti F; Horakova D; Kubala Havrdova E; Prat A; Girard M; Duquette P; Grand'Maison F; Onofrj M; Lugaresi A; Grammond P; Ozakbas, S; Amato MP; Gerlach O; Sola P; Ferraro D; Buzzard K; Skibina O; Lechner-Scott J; Alroughani R; Boz C; Van Pesch V; Cartechini E; Terzi M; Maimone D; Ramo-Tello C; Yamout B; Khoury SJ; La Spitaleri D; Sa MJ; Blanco Y; Granella F; Slee M; Butler E; Sidhom Y; Gouider R; Bergamaschi R; Karabudak R; Ampapa R; Sánchez-Menoyo JL; Prevost J; Castillo-Trivino T; McCombe PA; Macdonell R; Laureys G; Van Hijfte L; Oh J; Altintas A; De Gans K; Turkoglu R; Van Der Walt A; Butzkueven H; Vucic S; Barnett M; Cristiano E; Hodgkinson S; Iuliano G; Kappos L; Kuhle J; Shaygannejad V; Soysal A; Weinstock-Guttman B; Van Wijmeersch B; Kalincik T, 2023, 'Disability accrual in primary and secondary progressive multiple sclerosis', in Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, pp. 707 - 717, http://dx.doi.org/10.1136/jnnp-2022-330726

Pender MP; Hodgkinson SJ; Broadley S; Lindsey J; Ioannides ZA; Bagert B; Khanna R; Smith C; Gamelin L; Ye W; Willmer J; Bar-Or A, 2020, 'Phase i study of ata188, an off-the-shelf, allogeneic epstein-barr virus-targeted t-cell immunotherapy for progressive forms of multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 228 - 228, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100451&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jokubaitis V; Yeh W; Widyastuti P; Stankovich J; Gresle M; Havrdova EK; Horakova D; Vodehnalova K; Ozakbas S; Madueno SE; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Van der Walt A, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of postpartum relapse and disability progression', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 652 - 653, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547102220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butzkueven H; Spelman T; Ozakbas S; Kalincik T; Boz C; Buzzard K; Skibina O; Alroughani R; Karabudak R; Van der Walt A; Lechner-Scott J; Hodgkinson S; Laureys G; Van Hijfte L; Terzi M; Butler E; Macdonell R; Patti F; Van Pesch V; Slee M; Barnett M; Grammond P; Prevost J; Grand-Maison F; Taylor B; Kermode A; Mccombe P; Duquette P; Prat A; Girard M; Eichau Madueno S; Izquierdo G; Soysal A; Sanchez-Menoyo JL; Sotoca J; Muros-Le Rouzic E; Dirks P, 2020, 'Real-world experience with ocrelizumab in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 550 - 551, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547102002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Neill D; Sharma M; Gonzales B; Vandenheuval M; Tse B; Hodgkinson S, 2020, 'Switching from ocrelizumab to cladribine: real world data', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 67 - 68, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma N; O'Neill D; Al-Atiyah R; Sharma M; Tran G; Hall B; Hodgkinson S, 2020, 'The effect of cladribine upon naive and activated cd4(+) t regulatory cells in ms patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 314 - 314, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101180&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Maltby V; Lydon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T; Lechner-Scott J, 2020, 'Cladribine: a multicentre LOng-term efficacy Biomarker Australian Study (CLOBAS)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharmin S; Bovis F; Malpas C; Horakova D; Havrdova E; Ayuso GI; Eichau S; Trojano M; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Ferraro D; Terzi M; Hupperts RMM; Alroughani R; Boz C; Shaygannejad V; Van Pesch V; Kappos L; Lechner-Scott J; Bergamaschi R; Turkoglu R; Solaro C; Ramo-Tello C; Iuliano G; Granella F; Van Wijmeersch B; Spitaleri DLA; Fernandez Bolanos R; Slee M; McCombe P; Prevost J; Ampapa R; Ozakbas S; Luis Sanchez-Menoyo J; Soysal A; Vucic OS; Petersen T; Verheul F; Butler E; Hodgkinson S; Sidhom Y; Gouider R; Cristiano E; Olascoaga Urtaza FJ; Laura Saladino M; Barnett M; Deri N; Moore F; Rozsa C; Yamout B; Skibina O; Gray O; Campbell J; Sempere A; Singhal B; Fragoso Y; Shaw C; Kermode A; Petkovska-Boskova T; Taylor B; Simo M; Vella N; Shuey N; Alkhaboori J; Al-Harbi T; Macdonell R; Andres Dominguez J; Kister I; Csepany T; Vrech C; Kovacs K; Adella Sirbu C; Hughes S; Sormani MP; Butzkueven H; Kalincik T, 2020, 'Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058004051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butzkueven H; Spelman T; Madueno SE; Grand'Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2020, 'Real-world experience of oral cladribine use in the MSBase Registry', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058006063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Neill D; Hodgkinson S, 2020, 'Short term efficacy and safety outcomes after switching from Anti-CD20 DMTs to Cladribine in a real-world setting', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

L-Scott J; Maltby V; Lydon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T, 2019, 'Cladribine: a multicentre Long-term efficacy Biomarker Australian Study (CLOBAS)', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP63, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson S; Lizak N; Butler E; Lechner-Scott J; Slee M; McCombe P; Shaw C; Skibina O; Vucic S; Shuey N; Barnett M; Parratt J; Butzkueven H; Jack D; Fabris J; Kalincik T; Jokubaitis VG, 2019, 'Clinical experience with cladribine in patients with relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP64 - NP65, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson S; Butzkueven H; Spelman T; Patti F; Eichau S; Grand'Maison F; Kalincik T; Skibina O; Butler E, 2019, 'Real world experience with Cladribine (Mavenclad) in MSBase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP64, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma ND; Chiu C; Lam A; Sharma M; Baker S; Limbu B; Robinson C; Tran G; Hall BM; Hodgkinson SJ, 2019, 'Multiple sclerosis associated with increased activated CD4+CD25+Foxp3+T regulatory cells but reduced Th17 associated regulatory cells', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, Vol. 25, pp. 918 - 918, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303104036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Valente M; Cappelen-Smith C; Mcdougall A; Hodgkinson S; Thomas P; Cordato D, 2019, '"Code stroke" in the 24-hour time window from stroke onset: burden on hospital resources', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 14, pp. 9 - 9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485243200034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhaskar S; Saab J; Cappelen-Smith C; Cordato D; Cheung A; Manning N; Wenderoth J; Thomas P; Aouad P; Beran R; Hodgkinson S; McDougall A; Killingsworth M, 2019, 'Cryptogenic stroke is linked to cardioembolic aetiology: a histopathological study of thrombus retrieved after endovascular thrombectomy', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 20 - 20, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474481000035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhaskar S; Saab J; Cappelen-Smith C; Cordato D; Cheung A; Manning N; Wenderoth J; Thomas P; Calic Z; Firtko A; Beran R; Hodgkinson S; McDougall A; Killingsworth M, 2019, 'Erythrocyte-rich clots are associated with cardioembolic aetiology, reduced number of manoeuvres, and improved clinical outcome in acute ischemic stroke patients', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 180 - 180, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474481000283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lechner-Scott J; Maltby V; Lyndon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T, 2019, 'CLADRIBINE: A MULTICENTRE LONG-TERM EFFICACY BIOMARKER AUSTRALIAN STUDY (CLOBAS)', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Sydney, Vol. 90, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Sydney, 21 May 2019 - 24 May 2019, http://dx.doi.org/10.1136/jnnp-2019-anzan.119

Hall BM; Tran G; Verma ND; Robinson CM; Wilcox P; Hodgkinson SJ, 2019, 'Activation of naive CD4(+)CD25(+)FOXP3(+)Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500434&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall BM; Verma ND; Robinson CM; Wang C; Sharland A; Tran G; Wilcox P; Hodgkinson SJ, 2019, 'Recently alloactivated CD4(+)CD8(-)CD25(+)T regulatory cells express CD8alpha and are potent suppressor cells', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall BM; Tran G; Verma ND; Robinson CM; Wilcox P; Hodgkinson SJ, 2019, 'Activation of naive CD4+CD25+FOXP3+Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in The Journal of Immunology, The American Association of Immunologists, Vol. 202, pp. 116.16 - 116.16, http://dx.doi.org/10.4049/jimmunol.202.supp.116.16

Hall BM; Verma ND; Robinson CM; Wang C; Sharland A; Tran G; Wilcox P; Hodgkinson SJ, 2019, 'Recently alloactivated CD4+CD8−CD25+T regulatory cells express CD8alpha and are potent suppressor cells', in The Journal of Immunology, The American Association of Immunologists, Vol. 202, pp. 57.20 - 57.20, http://dx.doi.org/10.4049/jimmunol.202.supp.57.20

Hall BM; Rakesh P; Tran G; Hall R; Bedi S; Robinson CM; Sharland A; Wang C; Hodgkinson SJ; Verma ND, 2019, 'Th2 cytokines and specific donor alloantigen activated CD4+CD25+T cells reverse chronic rejection: role of IL-4 and IL-5 in promoting antigen-specific Treg', in The Journal of Immunology, The American Association of Immunologists, Vol. 202, pp. 186.11 - 186.11, http://dx.doi.org/10.4049/jimmunol.202.supp.186.11

Desai M; Alsahli K; Cheung A; Wenderoth J; Kohli A; Cappelen-Smith C; Cordato D; Tay K; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2019, 'Non-Contrast Computed Tomography Based Patient Selection Achieves Similar Outcomes to Advanced Neuroimaging in Late Time Window Endovascular Thrombectomy', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, HI, Honolulu, Vol. 50, presented at American-Heart-Association/American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium, HI, Honolulu, 06 February 2019 - 08 February 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478733400150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhaskar S; Thomas P; Cappelen-Smith C; McDougall A; Hodgkinson S; Cordato D, 2018, 'Factors associated with delayed hospital presentation for acute stroke events in South Western Sydney', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 13, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440952200111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma N; Lam A; Chiu C; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM, 2018, 'Alloactivation of Human CD4+CD25+CD127loCD45RA-Fox3hi Treg Population to Induce Potential Alloantigen Specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, SPAIN, Madrid, Vol. 102, pp. S145 - S145, presented at 27th International Congress of the Transplantation-Society (TTS), SPAIN, Madrid, 30 June 2018 - 05 July 2018, http://dx.doi.org/10.1097/01.tp.0000542769.25232.5b

Chiu CHY; Lam AD; Verma ND; Tran GT; Robinson CM; Hall BM; Hodgkinson SJ, 2018, 'Activation of Human Naive T Regulatory Cells for MS Therapy By Stimulation with Antigen and Interleukin-4', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 89 - 89, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lam AD; Chiu CHY; Verma ND; Robinson CM; Tran GT; Hall BM; Hodgkinson SJ, 2018, 'Phenotypic Analysis of T Regulatory Cells in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 93 - 94, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Trewin BP; Tilling J; Levy S; Hodgkinson SJ, 2018, 'Response to Immunosuppressive Therapy in Cerebral Amyloid Angiopathy-related Inflammation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Sydney, Vol. 25, pp. 492 - 492, presented at Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), AUSTRALIA, Sydney, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460691800161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wilcox P; Robinson CM; Verma ND; Nomura M; Tran GT; Carter N; Boyd R; Hodgkinson SJ; Hall BM, 2017, 'CD8 Expression Increases Suppressive Ability of CD4+CD25+Treg and is a Marker of Antigen-Specificity', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S37 - S37, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520351.47820.c8

Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM, 2017, 'Human CD4+CD25+CD127loFOXP3+Treg Activation by IL-4 and Alloantigen Induces Activated Treg that do not Express CD45RA and Express the IL-5 Receptor Alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S7 - S7, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520300.20897.2c

Hall BM; Hall RM; Verma ND; Robinson CM; Wilcox P; Tran GT; Wang C; Sharland A; Hodgkinson SJ, 2017, 'Interleukin 5 (IL-5) Treatment Prevents Chronic Allograft Rejection by Promoting IL-5 Receptor Expressing CD4+CD25+T Regulatory Ts2 Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S43 - S43, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520363.08810.76

Merkel B; Jokubaitis V; Spelman T; Lechner-Scott J; McCombe P; Slee M; Vucic S; Skibina O; Barnett M; Hodgkinson S; Butzkueven H; Kalincik T, 2017, 'TIMING OF HIGH-EFFICACY DISEASE MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.16

Stewart T; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Duquette P; Girard M; Prat A; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Shaygannejad V; Hupperts R; Alroughani R; Oreja-Guevara C; Pucci E; Boz C; Lechner-Scott J; Bergamaschi R; Van Pesch V; Iuliano G; Ramo C; Taylor B; Slee M; Spitaleri D; Granella F; Verheul F; McCombe P; Hodgkinson S; Amato MP; Vucic S; Gray O; Cristiano E; Barnett M; Sanchez Menoyo JL; Van Munster E; Saladino ML; Olascoaga J; Prevost J; Deri N; Shaw C; Singhal B; Moore F; Rozsa C; Shuey N; Skibina O; Kister I; Petkovska-Boskova T; Ampapa R; Kermode A; Butzkueven H; Jokubaitis V; Kalincik T, 2017, 'Contribution of different relapse phenotypes to disability in multiple sclerosis', in Multiple Sclerosis, Vol. 23, pp. 266 - 276, http://dx.doi.org/10.1177/1352458516643392

Kalincik T; Lizak N; Jokubaitis V; Butler E; Lechner-Scott J; Slee M; McCombe P; Shaw C; Skibina O; Vucic S; Shuey N; Barnett M; Parratt J; Butzkueven H; Hodgkinson S, 2016, 'Australian cladribine experience', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 289 - 290, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201360&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalincik T; Brown JW; Robertson N; Willis M; Scolding N; Pearson O; Ziemssen T; Hutchinson M; McGuigan C; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Alroughani R; Pucci E; Sola P; Hupperts R; Lechner-Scott J; Fernandez Bolanos R; Terzi M; Van Pesch V; Rozsa C; Grand'Maison F; Boz C; Granella F; Slee M; Spitaleri D; Olascoaga J; Bergamaschi R; Iuliano G; Verheul F; Vucic S; McCombe P; Hodgkinson S; Kovacs K; Sanchez-Menoyo JL; Ampapa R; Simo M; Ramo C; Cristiano E; Barnett M; Butzkueven H; Coles A, 2016, 'Comparison of 5-year treatment outcomes between alemtuzumab versus natalizumab, fingolimod and interferon beta-1a', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 829 - 832, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267203257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalincik T; Sobisek L; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Girard M; Prat A; Duquette P; Grammond P; Sola P; Hupperts R; Grand'Maison F; Pucci E; Boz C; Alroughani R; Van Pesch V; Lechner-Scott J; Terzi M; Bergamaschi R; Iuliano G; Granella F; Spitaleri D; Shaygannejad V; Oreja-Guevara C; Slee M; Ampapa R; Verheul F; McCombe P; Olascoaga J; Amato MP; Vucic S; Hodgkinson S; Ramo C; Flechter S; Cristiano E; Rozsa C; Moore F; Sanchez-Menoyo JL; Saladino ML; Barnett M; Butzkueven H, 2016, 'Individual response to disease modifying therapies: a global observational cohort study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 358 - 360, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haartsen J; Spelman T; Baker J; Agland S; Lechner-Scott J; Burke T; Vucic S; Rath L; Skibina O; Toubia M; Slee M; McGregor S; Taylor B; O'Connell A; Barnett M; Baker S; Sharma M; Hodgkinson S; Walters S; Kermode A; Hayes W; Butler E; Shuey N; Shaw C; Portley R; Hardy T; Tan IL; Butzkueven H, 2016, 'MSFIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 342 - 343, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201443&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jokubaitis VG; Kalincik T; Lorscheider J; Spelman T; Horakova D; Duquette P; Girard M; Prat A; Izquierdo G; Grammond P; Pucci E; Grand'Maison F; Granella F; Sola P; Bergamaschi R; Iuliano G; Spitaleri D; Hodgkinson S; Olascoaga J; Verheul F; McCombe P; Rozsa C; Lechner-Scott J; Terzi M; Hughes S; Saladino M-L; Lugaresi A; Trojano M; Butzkueven H, 2016, 'Pregnancy protects against long-term disability accrual in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 120 - 122, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma N; Robinson CM; Tran GT; Hall RM; Wilcox P; Hodgkinson SJ; Hall BM, 2016, 'Activation of Human CD4+CD25+CD127loFOXP3+Treg by IL-4 and alloantigen induces activated Treg that do not express CD45RA and express the IL-5 receptor alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S460 - S460, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953201100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson SJ; Hall BM; Hall RM; Robinson CM; Wilcox P; Tran GT; Wang C; Sharland A, 2016, 'Interleukin-5 therapy prevents chronic allograft rejection by induction of antigen specific CD4+CD25+T regulatory cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S65 - S65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall BM; Robinson CM; Wilcox P; Verma ND; Tran GT; Carter N; Boyd RA; Hodgkinson SJ, 2016, 'Recently alloactivated CD4+CD8-CD25+Treg express CD8 and are the antigen-specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S120 - S120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall B; Robinson C; Plain K; Verma N; Tran G; Carter N; Nomura M; Boyd R; Hodgkinson S, 2016, 'In Vitro Reactivity of CD4(+) T Cells Subsets from Hosts with Antigen Specific Transplant Tolerance Mediated by CD4(+)CD25(+) T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, Vol. 16, pp. 512 - 512, presented at American Transplant Congress, MA, Boston, 11 June 2016 - 15 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383373903337&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butzkueven H; Barnett M; Broadley S; Hodgkinson S; King J; Kneebone C; Slee M; Lechner-Scott J; Kermode A; Shuey N; Macdonell R; Chen Y; Naidoo K; Koendgen H, 2015, 'Efficacy and Safety of Natalizumab in Multiple Sclerosis: Interim Observational Program Results from an Australian Cohort.', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SOUTH KOREA, Seoul, Vol. 22, pp. 419 - 420, presented at 8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), SOUTH KOREA, Seoul, 19 November 2015 - 21 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372242400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson SJ; Hall BM; Hall RM; Tran GT; Robinson CM; Wang C; Sharland A, 2015, 'Interleukin-5 therapy prevents chronic allograft rejection by introduction of T regulatory cells.', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S4 - S4, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015

Hall BM; Robinson CM; Tran GT; Verma ND; Boyd RA; Hodgkinson SJ, 2015, 'Recently alloactivated CD4+CD8-CD25+TREG express CD8 and are the antigen-specific TREG', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S34 - S34, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015

Jokubaitis V; Spelman T; Kalincik T; Lorscheider J; McCombe P; Lechner-Scott J; Hodgkinson S; Butzkueven H, 2015, 'First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 21, pp. NP15 - NP15, presented at MS Research Australia Progress in MS Research Conference, AUSTRALIA, Melbourne, 29 October 2015 - 30 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lizak N; Lugaresi A; Alroughani R; Lechner-Scott J; Slee M; Hodgkinson S; Jokubaitis V; Spelman T; Butzkueven H; Kalincik T, 2015, 'Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 21, pp. NP14 - NP14, presented at MS Research Australia Progress in MS Research Conference, AUSTRALIA, Melbourne, 29 October 2015 - 30 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jokubaitis VG; Spelman T; Kalincik T; Travaglini D; Paolicelli D; Duquette P; Girard M; Prat A; Havrdova E; Horakova D; Izquierdo G; Grammond P; Pucci E; Grand'Maison F; Bergamaschi R; Granella F; Van Pesch V; Hupperts R; Iuliano G; Spitaleri D; Sola P; Boz C; Fernandez-Bolanos R; Petersen T; Verheul F; Olascoaga J; McCombe P; Rozsa C; Lechner-Scott J; Terzi M; Hodgkinson S; Ramo C; Saladino ML; Butzkueven H; Lugaresi A; Trojano M, 2015, '10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 100 - 102, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stewart T; Jokubaitis V; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Girard M; Duquette P; Prat A; Lugaresi A; Grammond P; Grand'Maison F; Sola P; Hupperts R; Petersen T; Pucci E; Bergamaschi R; Boz C; Oreja-Guevara C; Lechner-Scott J; Alroughani R; Ramo C; Van Pesch V; Fernandez-Bolanos R; Iuliano G; Rio ME; Granella F; Slee M; Verheul F; Spitaleri DLA; Amato MP; Hodgkinson S; McCombe P; Cabrera-Gomez JA; Barnett M; Flechter S; Olascoaga J; Vucic S; Sanchez-Menoyo JL; Cristiano E; Saladino ML; Moore F; Gray O; Shuey N; Rozsa C; Singhal B; Shaw C; Butzkueven H; Kalincik T, 2015, 'Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 726 - 728, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729402256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page